首页 > 最新文献

Phytomedicine最新文献

英文 中文
Panax notoginseng saponins ameliorate spinal cord injury by inhibiting JAK2/STAT3-mediated macrophage polarization: Enhanced delivery by ultrasound-targeted microbubble destruction 三七皂苷通过抑制JAK2/ stat3介导的巨噬细胞极化改善脊髓损伤:超声靶向微泡破坏增强传递
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-20 DOI: 10.1016/j.phymed.2026.157856
Yin Shi , Xuelian Chen , Shu Luo , Anjie Chen , Keyu Xie , Miao Fang , Jiaojiao Zhou

Background

Spinal cord injury (SCI) causes abnormal macrophage polarization, worsening inflammation and neuronal apoptosis, with current therapies showing limited efficacy. Panax Notoginseng Saponins (PNS) has anti-inflammatory and neuroprotective potential but is limited by low bioavailability. Ultrasound-targeted microbubble destruction (UTMD) can open the blood-spinal cord barrier to improve drug delivery.

Aim

To clarify the role of PNS and molecular mechanisms in regulating macrophage polarization for SCI and explore the effect of UTMD on enhancing PNS efficacy.

Methods

RAW264.7 macrophages and rat SCI models were used. Flow cytometry, RT-qPCR, Western blotting (WB), TUNEL staining, BBB scoring, and MRI were applied to detect polarization markers, JAK2/STAT3 pathway proteins, neuronal apoptosis, and neurological recovery.

Results

PNS dose-dependently promoted macrophage M2 polarization, inhibited the JAK2/STAT3 pathway, and reduced neuronal apoptosis. These effects were enhanced by the JAK2/STAT3 inhibitor AG490, while PNS also antagonized the pro-apoptotic action of the pathway activator colivelin. UTMD strengthened PNS’s effects in vitro. In rats, compared with the SCI-only group, the SCI+PNS group already showed therapeutic effects, with improved BBB scores, less M1 infiltration, suppressed JAK2/STAT3, and reduced apoptosis and cyst areas. Notably, the SCI+UTMD+PNS group exhibited even more pronounced improvements in these aspects and superior efficacy to both the SCI and SCI+PNS groups.

Conclusion

PNS inhibits JAK2/STAT3 to promote M2 polarization and reduce apoptosis. UTMD amplifies PNS’s efficacy, providing a novel SCI therapy strategy.
背景:脊髓损伤(SCI)引起巨噬细胞异常极化、炎症加重和神经元凋亡,目前的治疗方法疗效有限。三七皂苷(PNS)具有抗炎和神经保护作用,但生物利用度低。超声靶向微泡破坏(UTMD)可以打开血脊髓屏障,改善药物输送。目的:阐明PNS在脊髓损伤巨噬细胞极化调节中的作用及分子机制,探讨UTMD增强PNS疗效的作用。方法:采用RAW264.7巨噬细胞和大鼠脊髓损伤模型。应用流式细胞术、RT-qPCR、Western blotting (WB)、TUNEL染色、BBB评分和MRI检测极化标记物、JAK2/STAT3通路蛋白、神经元凋亡和神经恢复情况。结果:PNS剂量依赖性地促进巨噬细胞M2极化,抑制JAK2/STAT3通路,减少神经元凋亡。JAK2/STAT3抑制剂AG490增强了这些作用,而PNS也能拮抗该途径激活剂colcolvelin的促凋亡作用。UTMD在体外增强了PNS的作用。在大鼠中,与仅SCI组相比,SCI+PNS组已经显示出治疗效果,BBB评分改善,M1浸润减少,JAK2/STAT3抑制,细胞凋亡和囊肿面积减少。值得注意的是,SCI+UTMD+PNS组在这些方面表现出更明显的改善,且疗效优于SCI和SCI+PNS组。结论:PNS抑制JAK2/STAT3促进M2极化,减少细胞凋亡。UTMD增强了PNS的疗效,提供了一种新的脊髓损伤治疗策略。
{"title":"Panax notoginseng saponins ameliorate spinal cord injury by inhibiting JAK2/STAT3-mediated macrophage polarization: Enhanced delivery by ultrasound-targeted microbubble destruction","authors":"Yin Shi ,&nbsp;Xuelian Chen ,&nbsp;Shu Luo ,&nbsp;Anjie Chen ,&nbsp;Keyu Xie ,&nbsp;Miao Fang ,&nbsp;Jiaojiao Zhou","doi":"10.1016/j.phymed.2026.157856","DOIUrl":"10.1016/j.phymed.2026.157856","url":null,"abstract":"<div><h3>Background</h3><div>Spinal cord injury (SCI) causes abnormal macrophage polarization, worsening inflammation and neuronal apoptosis, with current therapies showing limited efficacy. Panax Notoginseng Saponins (PNS) has anti-inflammatory and neuroprotective potential but is limited by low bioavailability. Ultrasound-targeted microbubble destruction (UTMD) can open the blood-spinal cord barrier to improve drug delivery.</div></div><div><h3>Aim</h3><div>To clarify the role of PNS and molecular mechanisms in regulating macrophage polarization for SCI and explore the effect of UTMD on enhancing PNS efficacy.</div></div><div><h3>Methods</h3><div>RAW264.7 macrophages and rat SCI models were used. Flow cytometry, RT-qPCR, Western blotting (WB), TUNEL staining, BBB scoring, and MRI were applied to detect polarization markers, JAK2/STAT3 pathway proteins, neuronal apoptosis, and neurological recovery.</div></div><div><h3>Results</h3><div>PNS dose-dependently promoted macrophage M2 polarization, inhibited the JAK2/STAT3 pathway, and reduced neuronal apoptosis. These effects were enhanced by the JAK2/STAT3 inhibitor AG490, while PNS also antagonized the pro-apoptotic action of the pathway activator colivelin. UTMD strengthened PNS’s effects in vitro. In rats, compared with the SCI-only group, the SCI+PNS group already showed therapeutic effects, with improved BBB scores, less M1 infiltration, suppressed JAK2/STAT3, and reduced apoptosis and cyst areas. Notably, the SCI+UTMD+PNS group exhibited even more pronounced improvements in these aspects and superior efficacy to both the SCI and SCI+PNS groups.</div></div><div><h3>Conclusion</h3><div>PNS inhibits JAK2/STAT3 to promote M2 polarization and reduce apoptosis. UTMD amplifies PNS’s efficacy, providing a novel SCI therapy strategy.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157856"},"PeriodicalIF":8.3,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146126177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nelumbo nucifera extract alleviates UVB-induced hyperpigmentation via NOX4-mediated AMPK-YAP-ATG5 signaling pathway 荷兰花提取物通过nox4介导的AMPK-YAP-ATG5信号通路缓解uvb诱导的色素沉着。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-20 DOI: 10.1016/j.phymed.2026.157857
Cailing Wen , Jiaying Li , Canye Li , Xiuhan Song , Pingping Lv , Jieli Chen , Dong Wang , Shuyue Zhao , Meiling Tai , Xiaoyan Shen

Background

Hyperpigmentation is primarily caused by ultraviolet (UV) radiation, which triggers oxidative stress and melanin accumulation in the skin. Moderate UVB exposure activates autophagy, which facilitates cell repair, while prolonged UVB exposure disrupts this process, worsening skin damage and pigmentation. Nelumbo nucifera extract (NnE) drew our attention in our preliminary screening experiments for its potential to regulate keratinocyte autophagy. Nevertheless, the molecular mechanisms underlying the extract of NnE’s therapeutic effects and its bioactive constituents remain incompletely characterized.

Purpose

The aim of this study was to evaluate the effects of NnE on UVB-induced hyperpigmentation and to explore the mechanisms underlying its autophagy-promoting activity of bioactive ingredients.

Methods

B16 murine melanoma cells and human epidermal keratinocytes (HEKa) exposed to UVB radiation were used to model autophagy inhibition and melanosome accumulation. 3D pigmented skin organoid model and UVB-exposed guinea pigs were used to assess the effects of NnE on pigmentation. Various techniques, including western blot, immunofluorescence, and transcriptome sequencing, were employed to analyze autophagy regulation and melanosome clearance. Furthermore, we used molecular docking and in vitro enzyme activity detection methods to search for the active substances of NnE acting on the target.

Results

In HEKa cells, NnE effectively reversed UVB irradiation-induced inhibition of autophagy and promoted melanosome clearance. NnE also reduced the melanin content in HEKa cells. In MelaKutis® and UVB-exposed guinea pigs, topical application of NnE effectively alleviated pigmentation. Mechanistically, NnE suppressed the interaction between AMPK and YAP, thereby promoting nuclear translocation of YAP and upregulation of key autophagy-related genes, including ATG5, and ultimately enhancing autophagic activity. Finally, through molecular docking, cellular thermal shift assay (CETSA), drug affinity responsive target stability assay (DARTS), in vitro enzyme activity detection, and RNA interference, we demonstrated that quercetin-3-O-glucuronide, the major active constituent of NnE, exerts anti-photoaging effects by inhibiting NOX4 and subsequently regulating the AMPK/YAP/ATG5 signaling axis.

Conclusions

This study demonstrates that the anti-pigmentation effect of NnE and its bioactive compound, quercetin 3-O-glucuronide, is mediated through the YAP-ATG5 signaling axis and Q3Q-driven NOX4 inhibition, which establishes the mechanistic basis for their potential application in preventing UVB-induced skin pigmentation and provides a novel perspective for the development of anti-photoaging interventions.
背景:色素沉着主要是由紫外线(UV)辐射引起的,紫外线会引发皮肤氧化应激和黑色素积累。适度的UVB暴露会激活自噬,促进细胞修复,而长时间的UVB暴露会破坏这一过程,加剧皮肤损伤和色素沉着。荷叶莲提取物(NnE)在初步筛选实验中引起了我们的注意,因为它具有调节角质细胞自噬的潜力。然而,NnE提取物的治疗作用及其生物活性成分的分子机制仍未完全确定。目的:本研究旨在评价NnE对uvb诱导的色素沉着的影响,并探讨其生物活性成分促进自噬的作用机制。方法:采用暴露于UVB辐射下的B16小鼠黑色素瘤细胞和人表皮角质形成细胞(HEKa)进行自噬抑制和黑素小体积累的模型研究。采用三维着色皮肤类器官模型和uvb暴露豚鼠,观察NnE对皮肤色素沉着的影响。各种技术,包括免疫印迹、免疫荧光和转录组测序,被用来分析自噬调节和黑素小体清除。此外,我们采用分子对接和体外酶活性检测方法寻找作用于靶点的NnE活性物质。结果:在HEKa细胞中,NnE有效逆转UVB照射诱导的自噬抑制,促进黑素小体清除。NnE还能降低HEKa细胞中的黑色素含量。在MelaKutis®和uvb暴露的豚鼠中,局部应用NnE可有效缓解色素沉着。在机制上,NnE抑制AMPK与YAP的相互作用,从而促进YAP的核易位,上调包括ATG5在内的关键自噬相关基因,最终增强自噬活性。最后,我们通过分子对接、细胞热移实验(CETSA)、药物亲和力响应靶稳定性实验(DARTS)、体外酶活性检测和RNA干扰等方法,证明了槲皮素-3- o -葡糖苷是NnE的主要活性成分,通过抑制NOX4,进而调控AMPK/YAP/ATG5信号轴发挥抗光老化作用。结论:本研究表明,NnE及其生物活性化合物槲皮素3- o -葡糖苷的抗色素沉着作用是通过YAP-ATG5信号轴和q3q驱动的NOX4抑制介导的,这为其在预防uvb诱导的皮肤色素沉着方面的潜在应用奠定了机制基础,并为抗光老化干预措施的发展提供了新的视角。
{"title":"Nelumbo nucifera extract alleviates UVB-induced hyperpigmentation via NOX4-mediated AMPK-YAP-ATG5 signaling pathway","authors":"Cailing Wen ,&nbsp;Jiaying Li ,&nbsp;Canye Li ,&nbsp;Xiuhan Song ,&nbsp;Pingping Lv ,&nbsp;Jieli Chen ,&nbsp;Dong Wang ,&nbsp;Shuyue Zhao ,&nbsp;Meiling Tai ,&nbsp;Xiaoyan Shen","doi":"10.1016/j.phymed.2026.157857","DOIUrl":"10.1016/j.phymed.2026.157857","url":null,"abstract":"<div><h3>Background</h3><div>Hyperpigmentation is primarily caused by ultraviolet (UV) radiation, which triggers oxidative stress and melanin accumulation in the skin. Moderate UVB exposure activates autophagy, which facilitates cell repair, while prolonged UVB exposure disrupts this process, worsening skin damage and pigmentation. <em>Nelumbo nucifera</em> extract (NnE) drew our attention in our preliminary screening experiments for its potential to regulate keratinocyte autophagy. Nevertheless, the molecular mechanisms underlying the extract of NnE’s therapeutic effects and its bioactive constituents remain incompletely characterized.</div></div><div><h3>Purpose</h3><div>The aim of this study was to evaluate the effects of NnE on UVB-induced hyperpigmentation and to explore the mechanisms underlying its autophagy-promoting activity of bioactive ingredients.</div></div><div><h3>Methods</h3><div>B16 murine melanoma cells and human epidermal keratinocytes (HEKa) exposed to UVB radiation were used to model autophagy inhibition and melanosome accumulation. 3D pigmented skin organoid model and UVB-exposed guinea pigs were used to assess the effects of NnE on pigmentation. Various techniques, including western blot, immunofluorescence, and transcriptome sequencing, were employed to analyze autophagy regulation and melanosome clearance. Furthermore, we used molecular docking and <em>in vitro</em> enzyme activity detection methods to search for the active substances of NnE acting on the target.</div></div><div><h3>Results</h3><div>In HEKa cells, NnE effectively reversed UVB irradiation-induced inhibition of autophagy and promoted melanosome clearance. NnE also reduced the melanin content in HEKa cells. In MelaKutis® and UVB-exposed guinea pigs, topical application of NnE effectively alleviated pigmentation. Mechanistically, NnE suppressed the interaction between AMPK and YAP, thereby promoting nuclear translocation of YAP and upregulation of key autophagy-related genes, including ATG5, and ultimately enhancing autophagic activity. Finally, through molecular docking, cellular thermal shift assay (CETSA), drug affinity responsive target stability assay (DARTS), in vitro enzyme activity detection, and RNA interference, we demonstrated that quercetin-3-O-glucuronide, the major active constituent of NnE, exerts anti-photoaging effects by inhibiting NOX4 and subsequently regulating the AMPK/YAP/ATG5 signaling axis.</div></div><div><h3>Conclusions</h3><div>This study demonstrates that the anti-pigmentation effect of NnE and its bioactive compound, quercetin 3-O-glucuronide, is mediated through the YAP-ATG5 signaling axis and Q3Q-driven NOX4 inhibition, which establishes the mechanistic basis for their potential application in preventing UVB-induced skin pigmentation and provides a novel perspective for the development of anti-photoaging interventions.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157857"},"PeriodicalIF":8.3,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-tumor effects of Guggulsterone in osteosarcoma: Role of SIRT3-mediated PINK1-Parkin mitophagy activation 谷谷酮在骨肉瘤中的抗肿瘤作用:sirt3介导的PINK1-Parkin线粒体自噬激活的作用。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-20 DOI: 10.1016/j.phymed.2026.157860
Lingyuan Zeng , Shuwei Li , Kaidong Wu , Xiaoyu Bai , Long Zhang
Osteosarcoma (OS) is an aggressive primary bone malignancy characterized by limited therapeutic options and poor prognosis in advanced stages. Guggulsterone (GS), a naturally occurring plant-derived sterol, has recently been reported to suppress OS progression by inhibiting glycolysis via the MAPK signaling pathway. Although these findings underscore the therapeutic potential of GS in OS, the contribution of mitochondrial quality control to its antitumor activity remains unclear. Here, we report that GS disrupts mitochondrial integrity, elevates oxidative stress, and drives enhanced mitophagy in OS cells. RNA sequencing combined with functional assays revealed significant enrichment of mitophagy-related pathways, while rescue experiments confirmed that blocking mitophagy or SIRT3 activity markedly alleviated GS-induced mitochondrial damage, apoptosis, and growth inhibition. Mechanistically, GS activated the SIRT3-dependent PINK1/Parkin axis in a time-dependent manner, providing compelling evidence for its involvement in mitophagy regulation. Importantly, GS markedly inhibited OS tumor growth in vivo without causing detectable systemic toxicity. Collectively, our findings identify a mechanism distinct from the previously reported glycolysis/MAPK pathway, thereby broadening the mechanistic understanding of GS and underscoring its potential as a mitochondria-targeted therapeutic strategy for OS.
骨肉瘤(OS)是一种侵袭性的原发性骨恶性肿瘤,其特点是治疗选择有限,晚期预后差。Guggulsterone (GS)是一种天然存在的植物甾醇,最近有报道通过抑制MAPK信号通路的糖酵解来抑制OS的进展。尽管这些发现强调了GS在OS中的治疗潜力,但线粒体质量控制对其抗肿瘤活性的贡献尚不清楚。在这里,我们报道了GS破坏线粒体完整性,提高氧化应激,并在OS细胞中驱动增强的线粒体自噬。RNA测序结合功能分析显示,线粒体自噬相关通路显著富集,而救援实验证实,阻断线粒体自噬或SIRT3活性可显著减轻gs诱导的线粒体损伤、凋亡和生长抑制。在机制上,GS以时间依赖性的方式激活sirt3依赖性的PINK1/Parkin轴,为其参与有丝分裂调节提供了令人信服的证据。重要的是,GS在体内显著抑制OS肿瘤生长,而不会引起可检测到的全身毒性。总的来说,我们的发现确定了一种不同于先前报道的糖酵解/MAPK途径的机制,从而拓宽了对GS的机制理解,并强调了其作为线粒体靶向治疗OS策略的潜力。
{"title":"Anti-tumor effects of Guggulsterone in osteosarcoma: Role of SIRT3-mediated PINK1-Parkin mitophagy activation","authors":"Lingyuan Zeng ,&nbsp;Shuwei Li ,&nbsp;Kaidong Wu ,&nbsp;Xiaoyu Bai ,&nbsp;Long Zhang","doi":"10.1016/j.phymed.2026.157860","DOIUrl":"10.1016/j.phymed.2026.157860","url":null,"abstract":"<div><div>Osteosarcoma (OS) is an aggressive primary bone malignancy characterized by limited therapeutic options and poor prognosis in advanced stages. Guggulsterone (GS), a naturally occurring plant-derived sterol, has recently been reported to suppress OS progression by inhibiting glycolysis via the MAPK signaling pathway. Although these findings underscore the therapeutic potential of GS in OS, the contribution of mitochondrial quality control to its antitumor activity remains unclear. Here, we report that GS disrupts mitochondrial integrity, elevates oxidative stress, and drives enhanced mitophagy in OS cells. RNA sequencing combined with functional assays revealed significant enrichment of mitophagy-related pathways, while rescue experiments confirmed that blocking mitophagy or SIRT3 activity markedly alleviated GS-induced mitochondrial damage, apoptosis, and growth inhibition. Mechanistically, GS activated the SIRT3-dependent PINK1/Parkin axis in a time-dependent manner, providing compelling evidence for its involvement in mitophagy regulation. Importantly, GS markedly inhibited OS tumor growth <em>in vivo</em> without causing detectable systemic toxicity. Collectively, our findings identify a mechanism distinct from the previously reported glycolysis/MAPK pathway, thereby broadening the mechanistic understanding of GS and underscoring its potential as a mitochondria-targeted therapeutic strategy for OS.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157860"},"PeriodicalIF":8.3,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146132961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parthenolide ameliorates inflammation in sepsis via covalently targeting Trim33 and inhibiting NF-κB pathway. Parthenolide通过共价靶向Trim33和抑制NF-κB通路改善脓毒症的炎症。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-20 DOI: 10.1016/j.phymed.2026.157862
Xueling He, Chen Wang, Ruihao Zhang, Yuanyuan Wang, Ying Zhang, Tong Yang, Junzhe Zhang, Shuan Rao, Huan Tang, Xin Peng, Jigang Wang

Background: Sepsis, a life-threatening condition, arises from an aberrant or uncontrolled immune response of the host to severe infection. Timely and precise control of this inflammatory response is of paramount importance in sepsis prevention and constitutes the core of sepsis prevention efforts. Parthenolide (PA), recognized as an NF-κB inhibitor, has previously demonstrated its capacity to mitigate the inflammatory response. This study aimed to investigate whether and how PA can inhibit inflammation, thereby alleviating sepsis, and to profile functional target proteins using chemoproteomics strategy.

Methods: The cecal ligation and puncture (CLP) procedure was performed to induce a mouse model of sepsis, and lipopolysaccharide (LPS) was employed to establish a model of cellular inflammation in mouse mononuclear macrophage cells (RAW264.7) in vitro. Enzyme-linked immunosorbent assay (ELISA) and hematoxylin and eosin (H&E) staining were utilized to evaluate the therapeutic effects of PA on septic mice. In the in vitro experiments, streamlined cysteine activity-based protein profiling (SLC-ABPP) and proteomics techniques were employed to identify potential protein targets and molecular pathways responsible for the anti-inflammatory properties of PA.

Results: We demonstrated that PA could enhance the survival rate, reduce inflammatory cytokines release, ameliorate histopathological changes, and balance macrophage polarization in a sepsis model. Similarly, PA could effectively alleviate the inflammatory response in LPS-stimulated RAW264.7 cells. Chemoproteomics profiling revealed that the Trim33 protein was a potential covalent target of PA via cysteine engagement, and the expression changes of global proteins indicated by proteomics analysis suggested that PA mitigated inflammation by inhibiting the NF-κB pathway. Finally, through a series of molecular biology experiments, we confirmed that PA suppresses the NF-κB pathway by functionally binding to Trim33 and subsequently reducing the ubiquitin dependent degradation of Smad4, thereby exhibiting anti-inflammatory activity.

Conclusion: Our findings demonstrated that PA significantly mitigated inflammation in sepsis by targeting the Trim33 protein and consequently suppressing ubiquitination on Smad4 as well inhibiting the NF-κB pathway, thus providing new insights into the clinical use of PA in treatment of inflammation related diseases.

背景:脓毒症是一种危及生命的疾病,是由宿主对严重感染的异常或不受控制的免疫反应引起的。及时准确地控制这种炎症反应对脓毒症的预防至关重要,也是脓毒症预防工作的核心。Parthenolide (PA)被认为是一种NF-κB抑制剂,先前已经证明其减轻炎症反应的能力。本研究旨在探讨PA是否以及如何抑制炎症,从而减轻败血症,并利用化学蛋白质组学策略分析功能靶蛋白。方法:采用盲肠结扎穿刺法(CLP)诱导小鼠脓毒症模型,体外应用脂多糖(LPS)建立小鼠单核巨噬细胞(RAW264.7)细胞炎症模型。采用酶联免疫吸附法(ELISA)和苏木精伊红染色法(H&E)评价PA对脓毒症小鼠的治疗效果。在体外实验中,采用基于流线型半胱氨酸活性的蛋白谱分析(SLC-ABPP)和蛋白质组学技术来鉴定PA抗炎特性的潜在蛋白靶点和分子途径。结果:在脓毒症模型中,我们证明了PA可以提高脓毒症患者的存活率,减少炎症细胞因子的释放,改善组织病理变化,平衡巨噬细胞极化。同样,PA可以有效减轻lps刺激的RAW264.7细胞的炎症反应。化学蛋白质组学分析显示,Trim33蛋白是PA通过半胱氨酸参与的潜在共价靶点,蛋白质组学分析显示的全局蛋白表达变化表明PA通过抑制NF-κB途径减轻炎症。最后,通过一系列分子生物学实验,我们证实PA通过与Trim33的功能结合,进而降低Smad4的泛素依赖性降解,从而抑制NF-κB通路,从而表现出抗炎活性。结论:我们的研究结果表明,PA通过靶向Trim33蛋白,从而抑制Smad4上的泛素化,抑制NF-κB通路,显著减轻脓毒症中的炎症,从而为PA在炎症相关疾病的临床应用提供了新的见解。
{"title":"Parthenolide ameliorates inflammation in sepsis via covalently targeting Trim33 and inhibiting NF-κB pathway.","authors":"Xueling He, Chen Wang, Ruihao Zhang, Yuanyuan Wang, Ying Zhang, Tong Yang, Junzhe Zhang, Shuan Rao, Huan Tang, Xin Peng, Jigang Wang","doi":"10.1016/j.phymed.2026.157862","DOIUrl":"https://doi.org/10.1016/j.phymed.2026.157862","url":null,"abstract":"<p><strong>Background: </strong>Sepsis, a life-threatening condition, arises from an aberrant or uncontrolled immune response of the host to severe infection. Timely and precise control of this inflammatory response is of paramount importance in sepsis prevention and constitutes the core of sepsis prevention efforts. Parthenolide (PA), recognized as an NF-κB inhibitor, has previously demonstrated its capacity to mitigate the inflammatory response. This study aimed to investigate whether and how PA can inhibit inflammation, thereby alleviating sepsis, and to profile functional target proteins using chemoproteomics strategy.</p><p><strong>Methods: </strong>The cecal ligation and puncture (CLP) procedure was performed to induce a mouse model of sepsis, and lipopolysaccharide (LPS) was employed to establish a model of cellular inflammation in mouse mononuclear macrophage cells (RAW264.7) in vitro. Enzyme-linked immunosorbent assay (ELISA) and hematoxylin and eosin (H&E) staining were utilized to evaluate the therapeutic effects of PA on septic mice. In the in vitro experiments, streamlined cysteine activity-based protein profiling (SLC-ABPP) and proteomics techniques were employed to identify potential protein targets and molecular pathways responsible for the anti-inflammatory properties of PA.</p><p><strong>Results: </strong>We demonstrated that PA could enhance the survival rate, reduce inflammatory cytokines release, ameliorate histopathological changes, and balance macrophage polarization in a sepsis model. Similarly, PA could effectively alleviate the inflammatory response in LPS-stimulated RAW264.7 cells. Chemoproteomics profiling revealed that the Trim33 protein was a potential covalent target of PA via cysteine engagement, and the expression changes of global proteins indicated by proteomics analysis suggested that PA mitigated inflammation by inhibiting the NF-κB pathway. Finally, through a series of molecular biology experiments, we confirmed that PA suppresses the NF-κB pathway by functionally binding to Trim33 and subsequently reducing the ubiquitin dependent degradation of Smad4, thereby exhibiting anti-inflammatory activity.</p><p><strong>Conclusion: </strong>Our findings demonstrated that PA significantly mitigated inflammation in sepsis by targeting the Trim33 protein and consequently suppressing ubiquitination on Smad4 as well inhibiting the NF-κB pathway, thus providing new insights into the clinical use of PA in treatment of inflammation related diseases.</p>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"157862"},"PeriodicalIF":8.3,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional calibration of PPARγ by baicalein reverses bone-lipid imbalance in type 2 diabetic osteoporosis 黄芩素对PPARγ的功能校正可逆转2型糖尿病骨质疏松症的骨脂失衡。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157850
Hua Zhang , Bai hao Chen , Jianan Huang , Junzheng Yang , Jiacong Xiao , Peng Chen

Background

Type 2 diabetic osteoporosis (T2DOP) is characterized by excessive bone marrow adiposity and impaired osteogenesis, a pathology driven primarily by PPARγ-mediated dysregulation of the osteogenic–adipogenic differentiation balance in BMSCs under hyperglycemic conditions. Baicalein (BCL) is a natural flavonoid and a key active constituent of Gegen Qinlian Decoction (GQD), has shown regulatory potential in various metabolic disorders. However, its specific role and underlying mechanisms in T2DOP remain to be fully elucidated.

Methods

We treated db/db mice with BCL for 8 weeks. Micro-CT and histomorphometric analyses evaluated bone microarchitecture, while histochemical staining assessed marrow adiposity. Immunohistochemistry and Western blot analysis examined the expression of osteogenic and adipogenic markers. In vitro, we subjected high glucose-treated BMSCs to osteogenic/adipogenic induction in the presence of BCL. Differentiation was evaluated by ARS and Oil Red O staining. Furthermore, we employed molecular docking, CETSA, and molecular dynamics simulations to confirm direct binding between BCL and PPARγ.

Results

BCL significantly increased bone mineral density and trabecular number in db/db mice, while reducing marrow fat accumulation. In vitro, it promoted mineralization and suppressed lipid droplet formation. BCL downregulated PPARγ and adipogenic genes and enhanced osteogenic markers (Runx2, COL1A, OCN). Mechanistically, it bound strongly to the PPARγ ligand-binding domain, acting as a microenvironment-dependent modulator that recalibrates its transcriptional activity toward osteogenesis.

Conclusion

BCL attenuates T2DOP by directly targeting PPARγ and restoring its bone-lipid balance.
背景:2型糖尿病骨质疏松症(T2DOP)的特征是骨髓过度肥胖和成骨功能受损,这是一种主要由ppar γ介导的高血糖状态下骨髓间充质干细胞成骨-脂肪分化平衡失调所驱动的病理。黄芩素(Baicalein, BCL)是一种天然黄酮类化合物,是葛根芩连汤的关键活性成分,在多种代谢紊乱中显示出潜在的调节作用。然而,其在T2DOP中的具体作用和潜在机制仍有待充分阐明。方法:用BCL治疗db/db小鼠8周。显微ct和组织形态学分析评估骨微结构,而组织化学染色评估骨髓脂肪。免疫组织化学和Western blot检测成骨和脂肪标志物的表达。在体外,我们在BCL存在的情况下对高糖处理的骨髓间充质干细胞进行成骨/脂肪诱导。ARS和油红O染色评价分化程度。此外,我们利用分子对接、CETSA和分子动力学模拟来证实BCL与PPARγ之间的直接结合。结果:BCL显著增加db/db小鼠骨密度和骨小梁数量,减少骨髓脂肪堆积。在体外,它促进矿化和抑制脂滴形成。BCL下调PPARγ和脂肪生成基因,增强成骨标志物(Runx2, COL1A, OCN)。在机制上,它与PPARγ配体结合域紧密结合,作为微环境依赖性调节剂,重新校准其转录活性以促进成骨。结论:BCL通过直接靶向PPARγ,恢复其骨脂平衡,减轻T2DOP。
{"title":"Functional calibration of PPARγ by baicalein reverses bone-lipid imbalance in type 2 diabetic osteoporosis","authors":"Hua Zhang ,&nbsp;Bai hao Chen ,&nbsp;Jianan Huang ,&nbsp;Junzheng Yang ,&nbsp;Jiacong Xiao ,&nbsp;Peng Chen","doi":"10.1016/j.phymed.2026.157850","DOIUrl":"10.1016/j.phymed.2026.157850","url":null,"abstract":"<div><h3>Background</h3><div>Type 2 diabetic osteoporosis (T2DOP) is characterized by excessive bone marrow adiposity and impaired osteogenesis, a pathology driven primarily by PPARγ-mediated dysregulation of the osteogenic–adipogenic differentiation balance in BMSCs under hyperglycemic conditions. Baicalein (BCL) is a natural flavonoid and a key active constituent of Gegen Qinlian Decoction (GQD), has shown regulatory potential in various metabolic disorders. However, its specific role and underlying mechanisms in T2DOP remain to be fully elucidated.</div></div><div><h3>Methods</h3><div>We treated <em>db/db</em> mice with BCL for 8 weeks. Micro-CT and histomorphometric analyses evaluated bone microarchitecture, while histochemical staining assessed marrow adiposity. Immunohistochemistry and Western blot analysis examined the expression of osteogenic and adipogenic markers. In <em>vitro</em>, we subjected high glucose-treated BMSCs to osteogenic/adipogenic induction in the presence of BCL. Differentiation was evaluated by ARS and Oil Red O staining. Furthermore, we employed molecular docking, CETSA, and molecular dynamics simulations to confirm direct binding between BCL and PPARγ.</div></div><div><h3>Results</h3><div>BCL significantly increased bone mineral density and trabecular number in <em>db/db</em> mice, while reducing marrow fat accumulation. In <em>vitro</em>, it promoted mineralization and suppressed lipid droplet formation. BCL downregulated PPARγ and adipogenic genes and enhanced osteogenic markers (Runx2, COL1A, OCN). Mechanistically, it bound strongly to the PPARγ ligand-binding domain, acting as a microenvironment-dependent modulator that recalibrates its transcriptional activity toward osteogenesis.</div></div><div><h3>Conclusion</h3><div>BCL attenuates T2DOP by directly targeting PPARγ and restoring its bone-lipid balance.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157850"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spermidine alleviates ethanol-induced hepatocyte ferroptosis by restoring hepatic iron homeostasis via the gut-liver axis 亚精胺通过肠-肝轴恢复肝铁稳态,减轻乙醇诱导的肝细胞铁下垂
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157853
Yan-Jing Zhang , Dong Cheng , Wen-Huan Yao , Hui Li , Ming-Bao Zhang , Ying-Wen Mu , Xiu-Ning Zhang , Ge Song , Tao Zeng

Background & aims

Alcohol-related liver disease (ALD) remains a global public health challenge, highlighting the urgent need to uncover novel pathophysiological mechanisms and therapeutic targets. Spermidine, a natural polyamine abundant in dietary plant sources and present in all eukaryotic cells, exhibits versatile biological activities, yet its role in ALD development remains unclear. This study aimed to investigate the changes of spermidine metabolism and evaluate the hepatoprotective potential of spermidine in ALD.

Approach & results

The effects of ethanol on hepatic spermidine homeostasis and the hepatoprotective effects of spermidine were examined in clinical sample analysis, ethanol-fed mouse models, and in vitro systems (AML12 hepatocytes and Caco-2 monolayers). In this study, we provided the first comprehensive evidence from clinical samples, animal models, and cell culture systems demonstrating that ethanol consumption significantly reduced spermidine levels. Ethanol feeding induced an increase in serum aminotransferase activities, liver steatosis, oxidative stress, iron accumulation, and hepatocyte ferroptosis, which were significantly ameliorated by exogenous spermidine supplementation and exacerbated by the spermidine synthesis inhibitor DFMO. Mechanistically, spermidine inhibited iron uptake, prevented ferritin heavy chain (FTH) degradation likely by suppressing ferritinophagy, promoted iron export in hepatocytes, and reduced intestinal iron absorption. Notably, these protective effects were abolished in both global and hepatocyte-specific Nrf2-knockout mice, indicating dependence on NRF2 signaling.

Conclusions

These results identify ethanol-induced spermidine reduction as a previously unrecognized molecular event in the pathogenesis of ALD and highlight dietary spermidine supplementation as a promising strategy to counteract ethanol-driven iron dysregulation and hepatocyte ferroptosis.
背景目的酒精相关性肝病(ALD)仍然是一个全球性的公共卫生挑战,迫切需要发现新的病理生理机制和治疗靶点。亚精胺是一种天然多胺,广泛存在于植物膳食中,存在于所有真核细胞中,具有多种生物活性,但其在ALD发展中的作用尚不清楚。本研究旨在探讨ALD患者亚精胺代谢的变化,评价亚精胺对肝脏的保护作用。方法和结果通过临床样品分析、乙醇喂养小鼠模型和体外系统(AML12肝细胞和Caco-2单层)研究了乙醇对肝脏亚精胺稳态的影响和亚精胺的肝保护作用。在这项研究中,我们首次从临床样本、动物模型和细胞培养系统中提供了全面的证据,证明乙醇消耗显著降低了亚精胺水平。乙醇饲养引起血清转氨酶活性升高、肝脏脂肪变性、氧化应激、铁积累和肝细胞下垂,外源亚精胺添加显著改善了这些变化,亚精胺合成抑制剂DFMO则加剧了这些变化。在机制上,亚精胺抑制铁摄取,阻止铁蛋白重链(FTH)降解,可能通过抑制铁蛋白自噬,促进铁在肝细胞的输出,减少肠道铁吸收。值得注意的是,这些保护作用在全局和肝细胞特异性NRF2敲除小鼠中都被消除,这表明NRF2信号的依赖性。这些结果确定了乙醇诱导的亚精胺还原是ALD发病机制中一个以前未被认识到的分子事件,并强调了膳食补充亚精胺是一种有希望的策略,可以对抗乙醇驱动的铁失调和肝细胞铁凋亡。
{"title":"Spermidine alleviates ethanol-induced hepatocyte ferroptosis by restoring hepatic iron homeostasis via the gut-liver axis","authors":"Yan-Jing Zhang ,&nbsp;Dong Cheng ,&nbsp;Wen-Huan Yao ,&nbsp;Hui Li ,&nbsp;Ming-Bao Zhang ,&nbsp;Ying-Wen Mu ,&nbsp;Xiu-Ning Zhang ,&nbsp;Ge Song ,&nbsp;Tao Zeng","doi":"10.1016/j.phymed.2026.157853","DOIUrl":"10.1016/j.phymed.2026.157853","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Alcohol-related liver disease (ALD) remains a global public health challenge, highlighting the urgent need to uncover novel pathophysiological mechanisms and therapeutic targets. Spermidine, a natural polyamine abundant in dietary plant sources and present in all eukaryotic cells, exhibits versatile biological activities, yet its role in ALD development remains unclear. This study aimed to investigate the changes of spermidine metabolism and evaluate the hepatoprotective potential of spermidine in ALD.</div></div><div><h3>Approach &amp; results</h3><div>The effects of ethanol on hepatic spermidine homeostasis and the hepatoprotective effects of spermidine were examined in clinical sample analysis, ethanol-fed mouse models, and <em>in vitro</em> systems (AML12 hepatocytes and Caco-2 monolayers). In this study, we provided the first comprehensive evidence from clinical samples, animal models, and cell culture systems demonstrating that ethanol consumption significantly reduced spermidine levels. Ethanol feeding induced an increase in serum aminotransferase activities, liver steatosis, oxidative stress, iron accumulation, and hepatocyte ferroptosis, which were significantly ameliorated by exogenous spermidine supplementation and exacerbated by the spermidine synthesis inhibitor DFMO. Mechanistically, spermidine inhibited iron uptake, prevented ferritin heavy chain (FTH) degradation likely by suppressing ferritinophagy, promoted iron export in hepatocytes, and reduced intestinal iron absorption. Notably, these protective effects were abolished in both global and hepatocyte-specific <em>Nrf2</em>-knockout mice, indicating dependence on NRF2 signaling.</div></div><div><h3>Conclusions</h3><div>These results identify ethanol-induced spermidine reduction as a previously unrecognized molecular event in the pathogenesis of ALD and highlight dietary spermidine supplementation as a promising strategy to counteract ethanol-driven iron dysregulation and hepatocyte ferroptosis.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157853"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146039918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) mitigate doxorubicin-induced cardiotoxicity by inhibiting GPX4-mediated ferroptosis 西洋参衍生的细胞外囊泡样纳米颗粒(ageln)通过抑制gpx4介导的铁凋亡来减轻阿霉素诱导的心脏毒性
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157861
Teng Liu , Huan Wang , Ruifen Wang , Yumeng Jin , Yihan Wang , Shijie Wang , Xinrui Li , Yaru Wang , Zeyang Zhang , Ping Su , Songsong Wang , Huangge Zhang , Liwen Han

Background

Panacis Quinquefolii Radix (American ginseng, AG) has a well-documented history of use in cardiac protection. Nevertheless, the therapeutically active components responsible for its cardioprotective properties have not been fully elucidated. Extracellular vesicle-like nanoparticles (ELNs) have recently emerged as a promising class of natural nanocarriers with diverse applications in medicine and biology. However, it remains uncertain whether American Ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) exhibit cardioprotective effects.

Purpose

This investigation aims to analyze the effects of AGELNs on Doxorubicin-induced cardiotoxicity (DIC) and the mechanisms.

Methods

Gradient ultracentrifugation was employed to isolate and purify AGELNs, while HPLC was employed for both qualitative and quantitative analysis of saponin molecules in AGELNs. Fluorescently labeled AGELNs were used to assess their uptake in cardiac tissue and cardiomyocytes. DIC models in mice and zebrafish were employed to evaluate the effect of AGELNs against DIC. Transcriptomics, RT-PCR, immunofluorescence, Western blotting, and pharmacological agonist and antagonist treatments were used to elucidate the molecular mechanisms of AGELNs in vivo and in vitro.

Results

AGELNs significantly enhanced cardiac function in mice and zebrafish models, evidenced by increased fractional shortening (FS), stroke volume, heart rate, and pericardial sac areas. Concomitantly, AGELNs demonstrated pronounced cardiac accumulation in Dox-treated mice, zebrafish, and cardiomyocytes. Transcriptomic and cellular analyses demonstrated AGELNs attenuate DIC by suppressing lipid peroxidation and ferroptosis. Mechanistically, AGELNs predominantly inhibit cardiomyocyte ferroptosis by targeting GPX4 and activating the NRF2/HO-1/GPX4 pathway. Furthermore, the cardioprotective effect of AGELNs against DIC has been found to be closely linked to its specific combination of bioactive saponins, including Rb1, Rg1, Re, and Rd.

Conclusions

AGELNs significantly mitigated DIC by activating GPX4 and suppressing cardiomyocyte ferroptosis in vitro and in vivo. These insights are valuable for the formulation of AGELNs therapies aimed at combating DIC.
背景:西洋参(panacis Quinquefolii Radix, AG)在心脏保护方面有着良好的记录。然而,其心脏保护特性的治疗活性成分尚未完全阐明。细胞外囊泡样纳米颗粒(ELNs)是近年来出现的一类有前途的天然纳米载体,在医学和生物学上有着广泛的应用。然而,尚不清楚西洋参衍生的细胞外囊泡样纳米颗粒(AGELNs)是否具有心脏保护作用。目的分析ageln对阿霉素诱导的心脏毒性(DIC)的影响及其机制。方法采用梯度超离心分离纯化ageln,高效液相色谱法对ageln中皂苷分子进行定性和定量分析。使用荧光标记的ageln来评估其在心脏组织和心肌细胞中的摄取。采用小鼠和斑马鱼的DIC模型来评价ageln对DIC的作用。利用转录组学、RT-PCR、免疫荧光、Western blotting和药物激动剂和拮抗剂等方法,阐明ageln在体内和体外的分子机制。结果ageln显著增强了小鼠和斑马鱼模型的心功能,表现为分数缩短(FS)、搏量、心率和心包囊面积的增加。同时,ageln在dox处理的小鼠、斑马鱼和心肌细胞中表现出明显的心脏积聚。转录组学和细胞分析表明,ageln通过抑制脂质过氧化和铁下垂来减轻DIC。在机制上,ageln主要通过靶向GPX4和激活NRF2/HO-1/GPX4通路来抑制心肌细胞铁凋亡。此外,AGELNs对DIC的心脏保护作用与AGELNs与Rb1、Rg1、Re、rd等生物活性皂苷的特异性结合密切相关。结论AGELNs通过激活GPX4,抑制心肌细胞铁沉,在体外和体内均可显著减轻DIC。这些见解对于制定针对DIC的ageln疗法具有重要价值。
{"title":"American ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) mitigate doxorubicin-induced cardiotoxicity by inhibiting GPX4-mediated ferroptosis","authors":"Teng Liu ,&nbsp;Huan Wang ,&nbsp;Ruifen Wang ,&nbsp;Yumeng Jin ,&nbsp;Yihan Wang ,&nbsp;Shijie Wang ,&nbsp;Xinrui Li ,&nbsp;Yaru Wang ,&nbsp;Zeyang Zhang ,&nbsp;Ping Su ,&nbsp;Songsong Wang ,&nbsp;Huangge Zhang ,&nbsp;Liwen Han","doi":"10.1016/j.phymed.2026.157861","DOIUrl":"10.1016/j.phymed.2026.157861","url":null,"abstract":"<div><h3>Background</h3><div>Panacis Quinquefolii Radix (American ginseng, AG) has a well-documented history of use in cardiac protection. Nevertheless, the therapeutically active components responsible for its cardioprotective properties have not been fully elucidated. Extracellular vesicle-like nanoparticles (ELNs) have recently emerged as a promising class of natural nanocarriers with diverse applications in medicine and biology. However, it remains uncertain whether American Ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) exhibit cardioprotective effects.</div></div><div><h3>Purpose</h3><div>This investigation aims to analyze the effects of AGELNs on Doxorubicin-induced cardiotoxicity (DIC) and the mechanisms.</div></div><div><h3>Methods</h3><div>Gradient ultracentrifugation was employed to isolate and purify AGELNs, while HPLC was employed for both qualitative and quantitative analysis of saponin molecules in AGELNs. Fluorescently labeled AGELNs were used to assess their uptake in cardiac tissue and cardiomyocytes. DIC models in mice and zebrafish were employed to evaluate the effect of AGELNs against DIC. Transcriptomics, RT-PCR, immunofluorescence, Western blotting, and pharmacological agonist and antagonist treatments were used to elucidate the molecular mechanisms of AGELNs <em>in vivo</em> and <em>in vitro</em>.</div></div><div><h3>Results</h3><div>AGELNs significantly enhanced cardiac function in mice and zebrafish models, evidenced by increased fractional shortening (FS), stroke volume, heart rate, and pericardial sac areas. Concomitantly, AGELNs demonstrated pronounced cardiac accumulation in Dox-treated mice, zebrafish, and cardiomyocytes. Transcriptomic and cellular analyses demonstrated AGELNs attenuate DIC by suppressing lipid peroxidation and ferroptosis. Mechanistically, AGELNs predominantly inhibit cardiomyocyte ferroptosis by targeting GPX4 and activating the NRF2/HO-1/GPX4 pathway. Furthermore, the cardioprotective effect of AGELNs against DIC has been found to be closely linked to its specific combination of bioactive saponins, including Rb1, Rg1, Re, and Rd.</div></div><div><h3>Conclusions</h3><div>AGELNs significantly mitigated DIC by activating GPX4 and suppressing cardiomyocyte ferroptosis <em>in vitro</em> and <em>in vivo</em>. These insights are valuable for the formulation of AGELNs therapies aimed at combating DIC.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157861"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trigonelline regulates glycolysis and energy metabolism during hepatic fibrosis via Glut-1-HIF-1α axis: Focusing the interaction of macrophages and HSCs 葫芦巴碱通过Glut-1-HIF-1α轴调控肝纤维化过程中的糖酵解和能量代谢:聚焦巨噬细胞和造血干细胞的相互作用
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157854
Chong Gao , Wei Liu , Sai-Hu Liu , Shuang Zheng , Chen-Yu Wang , Xu Dai , Li-Hua Lian , Zhen-Yu Cui , Ji-Xing Nan , Yan-Ling Wu

Background

Reprogramming of aerobic glycolysis occurs with HSCs activation and is associated with regression of liver fibrosis. Trigonelline (TRG), a plant alkaloid extracted from Trigonella foenum-graecum L seeds, has a variety of pharmacological effect.

Purpose

The current study investigated the hepatoprotective effect and mechanism of TRG against hepatic fibrosis by regulating glycolysis.

Methods

Anti-hepatic fibrosis effects of TRG were detected in thioacetamide (TAA)-induced hepatic fibrosis mice. HSCs or LX-2 were stimulated with TGF-β or conditioned medium (CM) from LPS-stimulated THP-1, then incubated with TRG, phloretin (PHL), rosiglitazone (RGZ), siRNA Glut-1 or plasmid with Glut-1.

Results

TRG significantly reduced serum transaminase levels, liver histopathological changes, excessive collagen deposition, inflammatory response, and neutrophil recruitment in TAA-induced mice. TAA increased hepatic Glut-1, HIF-1α and key enzymes of glycolysis expressions, while TRG completely reversed this effect. TRG also obviously regulated the combination of Glut-1 and HIF-1α to affect glycolysis in activated HSCs. TRG could inhibit α-SMA, IL-6, IL1R1, and HIF-1α expressions accompanying inhibition of Glut-1, function as PHL (Glut-1 inhibitor). Glut-1 silencing weakened α-SMA, IL-6, IL1R1, and HIF-1α expressions and enhanced the effect of TRG in activated LX-2. TRG inhibited LX-2 activation caused by Glut-1 overexpression, even demonstrated in interaction between LX-2 and macrophages. Further, TRG shown that improved fibrogenesis and inflammatory response by inhibiting Glut-1 compared with PHL in vivo.

Conclusion

TRG could ameliorate hepatic fibrosis through inhibiting ECM excessive deposition and inflammatory response. Inhibiting Glut-1-HIF-1α axis and glycolysis was a potential therapeutic strategy for TRG ameliorating liver microenvironment, further against hepatic fibrosis.
有氧糖酵解的编程发生在造血干细胞的激活过程中,并与肝纤维化的消退有关。葫芦巴碱(TRG)是从葫芦巴种子中提取的一种植物生物碱,具有多种药理作用。目的探讨TRG通过调节糖酵解抑制肝纤维化的保肝作用及其机制。方法观察TRG对硫代乙酰胺(TAA)致肝纤维化小鼠的抗肝纤维化作用。用TGF-β或由lps刺激的THP-1形成的条件培养基(CM)刺激hsc或LX-2,然后用TRG、根皮素(PHL)、罗格列酮(RGZ)、siRNA Glut-1或含有Glut-1的质粒孵育。结果甘草多糖可显著降低taa诱导小鼠血清转氨酶水平、肝脏组织病理学改变、过多胶原沉积、炎症反应和中性粒细胞募集。TAA增加了肝脏Glut-1、HIF-1α和糖酵解关键酶的表达,而TRG完全逆转了这一作用。TRG还明显调节Glut-1和HIF-1α的结合,影响活化hsc的糖酵解。TRG可抑制α-SMA、IL-6、IL1R1和HIF-1α的表达,同时抑制Glut-1的表达,具有PHL (Glut-1抑制剂)的作用。Glut-1沉默可减弱α-SMA、IL-6、IL1R1和HIF-1α的表达,增强TRG在活化LX-2中的作用。TRG抑制Glut-1过表达引起的LX-2活化,甚至在LX-2与巨噬细胞的相互作用中也有表现。此外,与PHL相比,TRG在体内通过抑制Glut-1改善纤维生成和炎症反应。结论trg可通过抑制ECM过度沉积和炎症反应改善肝纤维化。抑制Glut-1-HIF-1α轴和糖酵解是TRG改善肝脏微环境,进一步抗肝纤维化的潜在治疗策略。
{"title":"Trigonelline regulates glycolysis and energy metabolism during hepatic fibrosis via Glut-1-HIF-1α axis: Focusing the interaction of macrophages and HSCs","authors":"Chong Gao ,&nbsp;Wei Liu ,&nbsp;Sai-Hu Liu ,&nbsp;Shuang Zheng ,&nbsp;Chen-Yu Wang ,&nbsp;Xu Dai ,&nbsp;Li-Hua Lian ,&nbsp;Zhen-Yu Cui ,&nbsp;Ji-Xing Nan ,&nbsp;Yan-Ling Wu","doi":"10.1016/j.phymed.2026.157854","DOIUrl":"10.1016/j.phymed.2026.157854","url":null,"abstract":"<div><h3>Background</h3><div>Reprogramming of aerobic glycolysis occurs with HSCs activation and is associated with regression of liver fibrosis. Trigonelline (TRG), a plant alkaloid extracted from <em>Trigonella foenum-graecum L</em> seeds, has a variety of pharmacological effect.</div></div><div><h3>Purpose</h3><div>The current study investigated the hepatoprotective effect and mechanism of TRG against hepatic fibrosis by regulating glycolysis.</div></div><div><h3>Methods</h3><div>Anti-hepatic fibrosis effects of TRG were detected in thioacetamide (TAA)-induced hepatic fibrosis mice. HSCs or LX-2 were stimulated with TGF-β or conditioned medium (CM) from LPS-stimulated THP-1, then incubated with TRG, phloretin (PHL), rosiglitazone (RGZ), siRNA Glut-1 or plasmid with Glut-1.</div></div><div><h3>Results</h3><div>TRG significantly reduced serum transaminase levels, liver histopathological changes, excessive collagen deposition, inflammatory response, and neutrophil recruitment in TAA-induced mice. TAA increased hepatic Glut-1, HIF-1α and key enzymes of glycolysis expressions, while TRG completely reversed this effect. TRG also obviously regulated the combination of Glut-1 and HIF-1α to affect glycolysis in activated HSCs. TRG could inhibit α-SMA, IL-6, IL1R1, and HIF-1α expressions accompanying inhibition of Glut-1, function as PHL (Glut-1 inhibitor). Glut-1 silencing weakened α-SMA, IL-6, IL1R1, and HIF-1α expressions and enhanced the effect of TRG in activated LX-2. TRG inhibited LX-2 activation caused by Glut-1 overexpression, even demonstrated in interaction between LX-2 and macrophages. Further, TRG shown that improved fibrogenesis and inflammatory response by inhibiting Glut-1 compared with PHL in <em>vivo</em>.</div></div><div><h3>Conclusion</h3><div>TRG could ameliorate hepatic fibrosis through inhibiting ECM excessive deposition and inflammatory response. Inhibiting Glut-1-HIF-1α axis and glycolysis was a potential therapeutic strategy for TRG ameliorating liver microenvironment, further against hepatic fibrosis.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157854"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146039454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arnicolide C induces ferroptosis in liver cancer through modulation of the HMOX1-TRC8 axis Arnicolide C通过调节HMOX1-TRC8轴诱导肝癌铁凋亡
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157859
Xuqi Zhao , Jinrui Wei , Yuxin Xie , Zhenkai Tan , Yuhan Jiang , Lichuan Wu
Liver cancer remains a significant therapeutic challenge, underscoring the urgent need for novel treatment strategies. Recently, induction of ferroptosis has emerged as a promising approach for treating malignant tumors. In this study, we identified Arcnicolide C (ArC) as an effective ferroptosis inducer in liver cancer. ArC markedly suppressed viability and clonogenic growth across multiple liver cancer cell lines. Notably, these anti-proliferative effects were selectively ameliorated by ferroptosis inhibitors. ArC treatment triggered characteristic ferroptotic events, including iron accumulation, lipid peroxidation, glutathione depletion, reactive oxygen species (ROS) generation, and loss of GPX4 enzymatic activity. Multi-omics analysis revealed HMOX1 as a key target, with ArC upregulating HMOX1 protein expression without altering its transcription. Functional studies confirmed the critical role of HMOX1 in ArC-induced ferroptosis, as HMOX1 knockdown attenuated ferroptotic cell death and restored proliferative capacity. Mechanistically, ArC interacted with HMOX1 protein, disrupted its binding to the E3 ubiquitin ligase TRC8, and thereby inhibited HMOX1 ubiquitination, leading to protein stabilization. In vivo, ArC potently inhibited the growth of liver cancer xenografts, exhibiting anti-tumor efficacy comparable to sorafenib but with an improved safety profile. This anti-tumor activity was also demonstrated to depend on the ferroptosis pathway. Collectively, our findings establish ArC as a ferroptosis inducer that acts through direct interaction with and stabilization of HMOX1, highlighting its potential as a novel therapeutic candidate for liver cancer.
肝癌仍然是一个重大的治疗挑战,强调迫切需要新的治疗策略。近年来,诱导铁下垂已成为治疗恶性肿瘤的一种很有前途的方法。在这项研究中,我们发现ArC是一种有效的肝癌铁下垂诱导剂。ArC可显著抑制多种肝癌细胞系的生存能力和克隆生长。值得注意的是,这些抗增殖作用选择性地改善了铁下垂抑制剂。ArC处理触发了特特性的铁致下沉事件,包括铁积累、脂质过氧化、谷胱甘肽耗竭、活性氧(ROS)的产生和GPX4酶活性的丧失。多组学分析显示HMOX1是一个关键靶点,ArC上调HMOX1蛋白的表达而不改变其转录。功能研究证实了HMOX1在arc诱导的铁细胞凋亡中的关键作用,因为HMOX1敲低可减轻铁细胞死亡并恢复增殖能力。机制上,ArC与HMOX1蛋白相互作用,破坏其与E3泛素连接酶TRC8的结合,从而抑制HMOX1泛素化,导致蛋白稳定。在体内,ArC有效地抑制了肝癌异种移植物的生长,显示出与索拉非尼相当的抗肿瘤功效,但安全性更高。这种抗肿瘤活性也被证明依赖于铁下垂途径。总的来说,我们的研究结果表明,ArC是一种铁下垂诱导剂,通过与HMOX1的直接相互作用和稳定作用,突出了它作为一种新的肝癌治疗候选药物的潜力。
{"title":"Arnicolide C induces ferroptosis in liver cancer through modulation of the HMOX1-TRC8 axis","authors":"Xuqi Zhao ,&nbsp;Jinrui Wei ,&nbsp;Yuxin Xie ,&nbsp;Zhenkai Tan ,&nbsp;Yuhan Jiang ,&nbsp;Lichuan Wu","doi":"10.1016/j.phymed.2026.157859","DOIUrl":"10.1016/j.phymed.2026.157859","url":null,"abstract":"<div><div>Liver cancer remains a significant therapeutic challenge, underscoring the urgent need for novel treatment strategies. Recently, induction of ferroptosis has emerged as a promising approach for treating malignant tumors. In this study, we identified Arcnicolide C (ArC) as an effective ferroptosis inducer in liver cancer. ArC markedly suppressed viability and clonogenic growth across multiple liver cancer cell lines. Notably, these anti-proliferative effects were selectively ameliorated by ferroptosis inhibitors. ArC treatment triggered characteristic ferroptotic events, including iron accumulation, lipid peroxidation, glutathione depletion, reactive oxygen species (ROS) generation, and loss of GPX4 enzymatic activity. Multi-omics analysis revealed HMOX1 as a key target, with ArC upregulating HMOX1 protein expression without altering its transcription. Functional studies confirmed the critical role of HMOX1 in ArC-induced ferroptosis, as HMOX1 knockdown attenuated ferroptotic cell death and restored proliferative capacity. Mechanistically, ArC interacted with HMOX1 protein, disrupted its binding to the E3 ubiquitin ligase TRC8, and thereby inhibited HMOX1 ubiquitination, leading to protein stabilization. In vivo, ArC potently inhibited the growth of liver cancer xenografts, exhibiting anti-tumor efficacy comparable to sorafenib but with an improved safety profile. This anti-tumor activity was also demonstrated to depend on the ferroptosis pathway. Collectively, our findings establish ArC as a ferroptosis inducer that acts through direct interaction with and stabilization of HMOX1, highlighting its potential as a novel therapeutic candidate for liver cancer.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"152 ","pages":"Article 157859"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146039916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linggui Zhugan Decoction mitigates post-myocardial infarction heart failure through modulation of cardiomyocyte F-actin cytoskeletal organization 灵桂竹肝汤通过调节心肌细胞f -肌动蛋白细胞骨架组织减轻心肌梗死后心力衰竭。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-19 DOI: 10.1016/j.phymed.2026.157851
Maojun Cheng , Liyang Li , Xing Huang , Fang Ding , Chengxun He , Changmao Dai , Jia Xu , Xiangyu He , Yayi Jiang , Guangmin Xu , Xueping Li

Background

Linggui Zhugan Decoction (LGZGD), a traditional Chinese formula for spleen-strengthening and yang-warming to resolve fluid retention, has consistently shown efficacy in preventing and treating heart failure. However, its underlying biological mechanisms remain incompletely understood.

Objective

This study aimed to investigate the therapeutic efficacy of LGZGD in a rat model of heart failure and in H9C2 cardiomyocytes, as well as to elucidate its effects on F-actin remodeling and the underlying mechanisms.

Methods

A rat model of heart failure post-myocardial infarction was established by ligating the left anterior descending coronary artery, followed by treatment with LGZGD for 4 weeks. The chemical constituents of the decoction and drug-containing serum were characterized using ultra-performance liquid chromatography. Network pharmacology analysis identified potential key therapeutic targets of LGZGD for heart failure treatment. An in vitro hypoxia/reoxygenation injury model was constructed in H9C2 cardiomyocytes. Additionally, siRNA-mediated ROCK knockdown was performed to investigate the mechanisms underlying LGZGD–mediated regulation of F-actin remodeling in cardiomyocytes.

Results

The results showed that LGZGD significantly improved cardiac function and pathological morphology in heart failure rats. Network pharmacology analysis identified RhoA as a key potential target for LGZGD in regulating F-actin in heart failure. Both in vivo and in vitro experiments further confirmed that LGZGD modulates F-actin cytoskeletal remodeling.

Conclusion

The present findings indicate that LGZGD significantly improves cardiac function in rats with heart failure. Furthermore, it enhances the stability of F-actin cytoskeletal organization and function in both heart tissues from rats with heart failure and H9C2 cardiomyocytes.
背景:灵归诸肝汤是一种健脾温阳解水的中药方剂,在预防和治疗心力衰竭方面一直表现出疗效。然而,其潜在的生物学机制仍不完全清楚。目的:研究LGZGD对心力衰竭大鼠模型和H9C2心肌细胞的治疗作用,阐明其对f -肌动蛋白重塑的影响及其机制。方法:结扎左冠状动脉前降支,建立心肌梗死后心力衰竭大鼠模型,给予LGZGD治疗4周。采用超高效液相色谱法对其化学成分和含药血清进行了表征。网络药理学分析确定了LGZGD治疗心力衰竭的潜在关键治疗靶点。建立H9C2心肌细胞体外缺氧/再氧化损伤模型。此外,通过sirna介导的ROCK敲低,研究lgzgd介导的心肌细胞f -肌动蛋白重塑调节的机制。结果:LGZGD能明显改善心力衰竭大鼠的心功能和病理形态。网络药理学分析发现RhoA是LGZGD在心力衰竭中调节F-actin的关键潜在靶点。体内和体外实验进一步证实了LGZGD调节F-actin细胞骨架重塑。结论:LGZGD对心力衰竭大鼠心功能有明显改善作用。此外,它还增强了心力衰竭大鼠心脏组织和H9C2心肌细胞中f -肌动蛋白细胞骨架组织和功能的稳定性。
{"title":"Linggui Zhugan Decoction mitigates post-myocardial infarction heart failure through modulation of cardiomyocyte F-actin cytoskeletal organization","authors":"Maojun Cheng ,&nbsp;Liyang Li ,&nbsp;Xing Huang ,&nbsp;Fang Ding ,&nbsp;Chengxun He ,&nbsp;Changmao Dai ,&nbsp;Jia Xu ,&nbsp;Xiangyu He ,&nbsp;Yayi Jiang ,&nbsp;Guangmin Xu ,&nbsp;Xueping Li","doi":"10.1016/j.phymed.2026.157851","DOIUrl":"10.1016/j.phymed.2026.157851","url":null,"abstract":"<div><h3>Background</h3><div>Linggui Zhugan Decoction (LGZGD), a traditional Chinese formula for spleen-strengthening and yang-warming to resolve fluid retention, has consistently shown efficacy in preventing and treating heart failure. However, its underlying biological mechanisms remain incompletely understood.</div></div><div><h3>Objective</h3><div>This study aimed to investigate the therapeutic efficacy of LGZGD in a rat model of heart failure and in H9C2 cardiomyocytes, as well as to elucidate its effects on F-actin remodeling and the underlying mechanisms.</div></div><div><h3>Methods</h3><div>A rat model of heart failure post-myocardial infarction was established by ligating the left anterior descending coronary artery, followed by treatment with LGZGD for 4 weeks. The chemical constituents of the decoction and drug-containing serum were characterized using ultra-performance liquid chromatography. Network pharmacology analysis identified potential key therapeutic targets of LGZGD for heart failure treatment. An in <em>vitro</em> hypoxia/reoxygenation injury model was constructed in H9C2 cardiomyocytes. Additionally, siRNA-mediated ROCK knockdown was performed to investigate the mechanisms underlying LGZGD–mediated regulation of F-actin remodeling in cardiomyocytes.</div></div><div><h3>Results</h3><div>The results showed that LGZGD significantly improved cardiac function and pathological morphology in heart failure rats. Network pharmacology analysis identified RhoA as a key potential target for LGZGD in regulating F-actin in heart failure. Both in <em>vivo</em> and in <em>vitro</em> experiments further confirmed that LGZGD modulates F-actin cytoskeletal remodeling.</div></div><div><h3>Conclusion</h3><div>The present findings indicate that LGZGD significantly improves cardiac function in rats with heart failure. Furthermore, it enhances the stability of F-actin cytoskeletal organization and function in both heart tissues from rats with heart failure and H9C2 cardiomyocytes.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157851"},"PeriodicalIF":8.3,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phytomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1